FR1414M - Pharmaceutical preparation comprising ion exchange resins containing phosphorus on which a basic drug is adsorbed, and treatment with the aid of this pharmaceutical preparation. - Google Patents

Pharmaceutical preparation comprising ion exchange resins containing phosphorus on which a basic drug is adsorbed, and treatment with the aid of this pharmaceutical preparation.

Info

Publication number
FR1414M
FR1414M FR866087A FR866087A FR1414M FR 1414 M FR1414 M FR 1414M FR 866087 A FR866087 A FR 866087A FR 866087 A FR866087 A FR 866087A FR 1414 M FR1414 M FR 1414M
Authority
FR
France
Prior art keywords
pharmaceutical preparation
adsorbed
aid
treatment
ion exchange
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR866087A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Filter Wallace and Tiernan Inc
Original Assignee
Wallace and Tiernan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wallace and Tiernan Inc filed Critical Wallace and Tiernan Inc
Application granted granted Critical
Publication of FR1414M publication Critical patent/FR1414M/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FR866087A 1961-06-26 1961-06-26 Pharmaceutical preparation comprising ion exchange resins containing phosphorus on which a basic drug is adsorbed, and treatment with the aid of this pharmaceutical preparation. Expired FR1414M (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH752561A CH415956A (en) 1961-06-26 1961-06-26 Process for the preparation of a pharmaceutical composition containing the remainder of a nitrogenous base

Publications (1)

Publication Number Publication Date
FR1414M true FR1414M (en) 1962-07-23

Family

ID=4326503

Family Applications (1)

Application Number Title Priority Date Filing Date
FR866087A Expired FR1414M (en) 1961-06-26 1961-06-26 Pharmaceutical preparation comprising ion exchange resins containing phosphorus on which a basic drug is adsorbed, and treatment with the aid of this pharmaceutical preparation.

Country Status (3)

Country Link
CH (1) CH415956A (en)
FR (1) FR1414M (en)
GB (1) GB934285A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2063499C (en) * 1992-03-19 1996-06-18 Leon Edward St. Pierre Ingestible polymeric phosphonium salts for the lowering of blood cholesterol
US6514492B1 (en) 1999-07-14 2003-02-04 Schering-Plough Veterinary Corporation Taste masking of oral quinolone liquid preparations using ion exchange resins
WO2007144048A2 (en) * 2006-06-12 2007-12-21 Dsm Fine Chemicals Austria Nfg Gmbh & Co. Kg Presentation form for the oral administration of phenothiazine dyes, its production and use
WO2009007376A1 (en) * 2007-07-09 2009-01-15 Dsm Fine Chemicals Austria Nfg Gmbh & Co Kg Pharmaceutical compositions for peroral administration of phenothiazine dyestuffs

Also Published As

Publication number Publication date
CH415956A (en) 1966-06-30
GB934285A (en) 1963-08-14

Similar Documents

Publication Publication Date Title
FR3570M (en) Pharmaceutical compositions containing antibiotics of the oxytetracycline type having improved stability.
BE764305A (en) THERAPEUTIC AGENT FOR THE TREATMENT OF INFLAMATORY CONDITIONS.
FR1433632A (en) Improvements in the preparation of ion exchange resins and products obtained
FR1414M (en) Pharmaceutical preparation comprising ion exchange resins containing phosphorus on which a basic drug is adsorbed, and treatment with the aid of this pharmaceutical preparation.
BE619012A (en) Process for the preparation of alkyl-substituted arylnaphthenes and / or arylnaphthene.
FR2319M (en) Drug for the treatment of digestive tract disorders based on new salts of glycyrrhetinic acid.
FR1958M (en) New drug in particular for the treatment of andropause, senescence and disorders of protein anabolism and cell building.
FR2944M (en) Medicine for the treatment of cough based on 2-amino-6-methylheptane.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR1489M (en) 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases.
FR2603M (en) New drug in particular for the treatment of hepatic degenerations of chemical, bacterial, toxic or senile origin.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR1904M (en) Drug based on n-acyl-hydroxyamino-acetic acid for the treatment of tumors.
FR2929M (en) Pharmaceutical composition for the treatment of arthritic and rheumatic conditions.
IL22850A (en) 3-chloro-1,2,5-thiazdiazole-4-carboxylic acid being an intermediate in the preparation of sulfa drugs
FR1248471A (en) Preparation of ion exchange resins
FR1829M (en) New drug, in particular for the treatment of blood coagulability disorders.
BE598692A (en) New drug for the treatment of virus diseases, especially influenza
FR1039M (en) Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
CH407981A (en) Process for the preparation of isoprene
FR1935M (en) Medicinal product based on 6-acylaminopenicillanic acid for the treatment of infectious diseases.
FR1224M (en) Homeoflora treatment of the sebaceous glands.
FR1638M (en) Composition for the treatment of hemorrhoids, based on adrenalone heparinate.
OA00900A (en) Process for the preparation of a pharmaceutical diluent.